-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-06-26
HYHHF:OTC- (USD)
COMMON STOCK | Medical Care Facilities |
Last Closing
USD 5Change
0.00 (0.00)%Market Cap
USD 3.16BVolume
N/AVerdict
Verdict
Values as of: 2024-06-26
COMMON STOCK | Medical Care Facilities |
Last Closing
USD 5Change
0.00 (0.00)%Market Cap
USD 3.16BVolume
N/AVerdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
FSNUY | Fresenius SE & Co KGaA ADR |
+0.06 (+0.80%) |
USD 17.80B |
FSNUF | Fresenius SE & Co. KGaA |
N/A |
USD 17.32B |
FMCQF | Fresenius Medical Care AG & Co.. |
N/A |
USD 13.85B |
BDULF | Bangkok Dusit Medical Services.. |
N/A |
USD 13.23B |
JDHIY | JD Health International Inc |
N/A |
USD 13.08B |
BDUUY | Bangkok Dusit Medical Services.. |
N/A |
USD 12.69B |
BDUUF | Bangkok Dusit Medical Services.. |
N/A |
USD 12.31B |
JDHIF | JD Health International Inc |
N/A |
USD 11.64B |
IHHHF | IHH Healthcare Berhad |
N/A |
USD 11.26B |
RMYHY | Ramsay Health Care Ltd ADR |
N/A |
USD 7.87B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
PPLN:CA | Global X Pipelines & Ener.. | 8.59 % | 0.00 % |
+0.02 (+0.19%) |
N/A |
ZIN:CA | BMO S&P/TSX Equal Weight .. | 2.74 % | 0.59 % |
+0.34 (+0.19%) |
CAD 0.05B |
CIF:CA | iShares Global Infrastruc.. | 0.00 % | 0.72 % |
-0.23 (0.19%) |
CAD 0.45B |
CVY | Invesco Zacks Multi-Asset.. | 0.00 % | 0.65 % |
+0.16 (+0.19%) |
USD 0.11B |
HOG:CA | Horizons Pipelines & Ener.. | 0.00 % | 0.64 % |
N/A |
CAD 0.03B |
PSCF | Invesco S&P SmallCap Fina.. | 0.00 % | 0.29 % |
+0.79 (+0.19%) |
USD 0.02B |
RDOG | ALPS REIT Dividend Dogs E.. | 0.00 % | 0.00 % |
+0.61 (+0.19%) |
USD 0.01B |
Market Performance vs. Industry/Classification (Medical Care Facilities) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | 3.16B | 81% | B- | 79% | B- |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.